|4May 7, 2:43 PM ET

TRANSGENOMIC INC 4

4 · TRANSGENOMIC INC · Filed May 7, 2013

Insider Transaction Report

Form 4
Period: 2013-05-03
COLONNESE MARK P
Chief Financial Officer
Transactions
  • Award

    Purchase Option

    2013-05-03+66,66766,667 total
    Exercise: $0.35From: 2014-06-01Exp: 2023-05-02Common Stock (66,667 underlying)
  • Award

    Purchase Option

    2013-05-03+66,66766,667 total
    Exercise: $0.35From: 2015-06-01Exp: 2023-05-02Common Stock (66,667 underlying)
  • Award

    Purchase Option

    2013-05-03+66,66666,666 total
    Exercise: $0.35From: 2016-06-01Exp: 2023-05-02Common Stock (66,666 underlying)
Footnotes (2)
  • [F1]Common Stock, par value $.01 per share of Transgenomic, Inc.
  • [F2]The various numbers listed in Columns 5, 7 and 9 relate to a single option grant which entitles the reporting person to purchase up to an aggregate of 200,000 shares of Common Stock, par value $.01 per share of Transgenomic, Inc.

Documents

1 file
  • 4
    v344036_4.xmlPrimary

    OWNERSHIP DOCUMENT